Synthesis of new generation triazolyl- and isoxazolyl-containing 6-nitro-2,3-dihydroimidazooxazoles as anti-TB agents: in vitro, structure–activity relationship, pharmacokinetics and in vivo evaluation

Author:

Munagala Gurunadham12345,Yempalla Kushalava Reddy12345,Singh Samsher52346,Sharma Sumit12345,Kalia Nitin Pal6234,Rajput Vikrant Singh52346,Kumar Sunil52346,Sawant Sanghapal D.12345,Khan Inshad Ali52346,Vishwakarma Ram A.12345,Singh Parvinder Pal12345

Affiliation:

1. Medicinal Chemistry Division

2. CSIR-Indian Institute of Integrative Medicine

3. Jammu 180 001

4. India

5. Academy of Scientific and Innovative Research

6. Clinical Microbiology

Abstract

Promising nitroimidazoloxazole scaffold gives another novel triazolyl-containing 6-nitro-2,3-dihydroimidazooxazole as anti-TB lead.

Funder

Council of Scientific and Industrial Research

Publisher

Royal Society of Chemistry (RSC)

Subject

Organic Chemistry,Physical and Theoretical Chemistry,Biochemistry

Reference33 articles.

1. India reports cases of totally drug-resistant tuberculosis

2. A new era for global tuberculosis control

3. K. Lonnroth , E.Jaramillo, B.Williams, C.Dye and M.Raviglione, in Tuberculosis: The Role of Risk Factors and Social Determinants, ed. E. Blas and A. S. Kurup, World Health Organization, WHO Press, Switzerland, 2010, p. 220

4. World Health Organization (WHO) , Treatment of tuberculosis: Guidelines for national programmes, WHO Press, Geneva, Switzerland, 4th edn, 2009

5. Prospects for Clinical Introduction of Nitroimidazole Antibiotics for the Treatment of Tuberculosis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3